The global Antifungal Nail Drug market was valued at US$ 3541 million in 2025 and is anticipated to reach US$ 5709 million by 2032, at a CAGR of 6.6% from 2026 to 2032.

Antifungal Nail Drug Market

Antifungal Nail Drugs refer to prescription and over-the-counter pharmaceutical formulations specifically developed for the treatment of fungal nail infections such as onychomycosis and tinea unguium. These products include systemic oral antifungal agents and topical transungual formulations. By inhibiting or eliminating dermatophytes, yeasts, and molds, they prevent fungal proliferation within the nail plate and nail bed, enabling infection control and structural nail recovery. Compared with conventional antifungal skin medications, antifungal nail drugs must overcome the dense keratin barrier and limited drug permeability of the nail plate, as well as long treatment cycles. Therefore, formulation design emphasizes enhanced penetration, sustained release performance, and safety tolerability. These products are widely used in dermatology clinics, podiatry centers, and primary healthcare institutions, with expanding presence in retail pharmacies and home-care settings, representing a key segment within the dermatological anti-infective market.The average gross profit margin of this product is 45%.

The rising global incidence of fungal infections, coupled with population aging and increasing prevalence of chronic diseases such as diabetes, is significantly driving clinical demand for antifungal nail drugs. Growing awareness of personal hygiene and aesthetic health has shifted treatment behavior from passive care to proactive management. Advances in pharmaceutical research have introduced novel molecules and improved formulations, enhancing efficacy and patient adherence. Expanding healthcare coverage and improved primary care capabilities are accelerating product penetration in emerging markets, forming a solid foundation for sustained industry growth.

Long treatment durations often lead to suboptimal patient adherence, affecting therapeutic outcomes and repurchase rates. Systemic oral antifungal drugs may carry potential safety risks, including hepatotoxicity, requiring careful monitoring and limiting use in certain populations. The entry of generic products intensifies price competition and compresses margins for innovative brands. Regulatory variations and patent protection differences across countries further complicate international expansion. Additionally, consumer preference for low-cost or unregulated alternatives poses challenges to market standardization.

Healthcare providers increasingly emphasize evidence-based practice and combination therapy, with integrated oral and topical regimens gaining traction. Retail markets prioritize convenience and advanced penetration technologies, supporting growth of film-forming, fast-drying, and single-application formats. The rise of telemedicine and online consultation platforms facilitates prescription access and follow-up, stabilizing long-term medication demand. Within chronic disease management frameworks, nail infections associated with diabetic foot care are emerging as a significant growth subsegment.

Key upstream materials include antifungal active pharmaceutical ingredients, solvent systems, penetration enhancers, and film-forming agents. High-purity raw materials and controlled crystalline forms have become central to quality competitiveness. Stricter environmental regulations are promoting the adoption of low-toxicity solvents and greener manufacturing processes. Certain critical raw materials exhibit supply concentration, making them vulnerable to international trade fluctuations and environmental policies. Strengthened supply chain stability and traceability systems are therefore essential to ensure product consistency and safety

This report delivers a comprehensive overview of the global Antifungal Nail Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Antifungal Nail Drug. The Antifungal Nail Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Antifungal Nail Drug market comprehensively. Regional market sizes by Type, by Application, by End Users, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Antifungal Nail Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Antifungal Nail Drug Market Report

Report Metric	Details
Report Name	Antifungal Nail Drug Market
Accounted market size in 2025	US$ 3541 million
Forecasted market size in 2032	US$ 5709 million
CAGR	6.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Azoles Allylamines Morpholines Polyene Antifungals
Segment by End Users	Dermatology Clinic General Hospital Home Care
Segment by Administration Route	Topical Drugs Oral Drugs
Segment by Application	Hospital Sales Retail Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bausch Health, Novartis, GSK, Sanofi, Bayer, Merck & Co., AstraZeneca, Europharma, CR Sanjiu, Taiji Group, Tonrentang, 3M Health Care, Galderma, Letai Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End Users, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Antifungal Nail Drug companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Antifungal Nail Drug Market growing?

Ans: The Antifungal Nail Drug Market witnessing a CAGR of 6.6% during the forecast period 2026-2032.

What is the Antifungal Nail Drug Market size in 2032?

Ans: The Antifungal Nail Drug Market size in 2032 will be US$ 5709 million.

Who are the main players in the Antifungal Nail Drug Market report?

Ans: The main players in the Antifungal Nail Drug Market are Pfizer, Bausch Health, Novartis, GSK, Sanofi, Bayer, Merck & Co., AstraZeneca, Europharma, CR Sanjiu, Taiji Group, Tonrentang, 3M Health Care, Galderma, Letai Pharma

What are the Application segmentation covered in the Antifungal Nail Drug Market report?

Ans: The Applications covered in the Antifungal Nail Drug Market report are Hospital Sales, Retail Pharmacy, Other

What are the Type segmentation covered in the Antifungal Nail Drug Market report?

Ans: The Types covered in the Antifungal Nail Drug Market report are Azoles, Allylamines, Morpholines, Polyene Antifungals

What are the End User segmentation covered in the Antifungal Nail Drug Market report?

Ans: The End users covered in the Antifungal Nail Drug Market report are Dermatology Clinic, General Hospital, Home Care

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Antifungal Nail Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Azoles

1.2.3 Allylamines

1.2.4 Morpholines

1.2.5 Polyene Antifungals

1.3 Market by End Users

1.3.1 Global Antifungal Nail Drug Market Size Growth Rate by End Users: 2021 vs 2025 vs 2032

1.3.2 Dermatology Clinic

1.3.3 General Hospital

1.3.4 Home Care

1.4 Market by Administration Route

1.4.1 Global Antifungal Nail Drug Market Size Growth Rate by Administration Route: 2021 vs 2025 vs 2032

1.4.2 Topical Drugs

1.4.3 Oral Drugs

1.5 Market by Application

1.5.1 Global Antifungal Nail Drug Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Hospital Sales

1.5.3 Retail Pharmacy

1.5.4 Other

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Antifungal Nail Drug Market Perspective (2021–2032)

2.2 Global Antifungal Nail Drug Growth Trends by Region

2.2.1 Global Antifungal Nail Drug Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Antifungal Nail Drug Historic Market Size by Region (2021–2026)

2.2.3 Antifungal Nail Drug Forecasted Market Size by Region (2027–2032)

2.3 Antifungal Nail Drug Market Dynamics

2.3.1 Antifungal Nail Drug Industry Trends

2.3.2 Antifungal Nail Drug Market Drivers

2.3.3 Antifungal Nail Drug Market Challenges

2.3.4 Antifungal Nail Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Antifungal Nail Drug Players by Revenue

3.1.1 Global Top Antifungal Nail Drug Players by Revenue (2021–2026)

3.1.2 Global Antifungal Nail Drug Revenue Market Share by Players (2021–2026)

3.2 Global Top Antifungal Nail Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Antifungal Nail Drug Revenue

3.4 Global Antifungal Nail Drug Market Concentration Ratio

3.4.1 Global Antifungal Nail Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Antifungal Nail Drug Revenue in 2025

3.5 Global Key Players of Antifungal Nail Drug Head Offices and Areas Served

3.6 Global Key Players of Antifungal Nail Drug, Products and Applications

3.7 Global Key Players of Antifungal Nail Drug, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Antifungal Nail Drug Breakdown Data by Type

4.1 Global Antifungal Nail Drug Historic Market Size by Type (2021–2026)

4.2 Global Antifungal Nail Drug Forecasted Market Size by Type (2027–2032)

5 Antifungal Nail Drug Breakdown Data by Application

5.1 Global Antifungal Nail Drug Historic Market Size by Application (2021–2026)

5.2 Global Antifungal Nail Drug Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Antifungal Nail Drug Market Size (2021–2032)

6.2 North America Antifungal Nail Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Antifungal Nail Drug Market Size by Country (2021–2026)

6.4 North America Antifungal Nail Drug Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Antifungal Nail Drug Market Size (2021–2032)

7.2 Europe Antifungal Nail Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Antifungal Nail Drug Market Size by Country (2021–2026)

7.4 Europe Antifungal Nail Drug Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Antifungal Nail Drug Market Size (2021–2032)

8.2 Asia-Pacific Antifungal Nail Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Antifungal Nail Drug Market Size by Region (2021–2026)

8.4 Asia-Pacific Antifungal Nail Drug Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Antifungal Nail Drug Market Size (2021–2032)

9.2 Latin America Antifungal Nail Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Antifungal Nail Drug Market Size by Country (2021–2026)

9.4 Latin America Antifungal Nail Drug Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Antifungal Nail Drug Market Size (2021–2032)

10.2 Middle East & Africa Antifungal Nail Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Antifungal Nail Drug Market Size by Country (2021–2026)

10.4 Middle East & Africa Antifungal Nail Drug Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Antifungal Nail Drug Introduction

11.1.4 Pfizer Revenue in Antifungal Nail Drug Business (2021–2026)

11.1.5 Pfizer Recent Development

11.2 Bausch Health

11.2.1 Bausch Health Company Details

11.2.2 Bausch Health Business Overview

11.2.3 Bausch Health Antifungal Nail Drug Introduction

11.2.4 Bausch Health Revenue in Antifungal Nail Drug Business (2021–2026)

11.2.5 Bausch Health Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Antifungal Nail Drug Introduction

11.3.4 Novartis Revenue in Antifungal Nail Drug Business (2021–2026)

11.3.5 Novartis Recent Development

11.4 GSK

11.4.1 GSK Company Details

11.4.2 GSK Business Overview

11.4.3 GSK Antifungal Nail Drug Introduction

11.4.4 GSK Revenue in Antifungal Nail Drug Business (2021–2026)

11.4.5 GSK Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Details

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Antifungal Nail Drug Introduction

11.5.4 Sanofi Revenue in Antifungal Nail Drug Business (2021–2026)

11.5.5 Sanofi Recent Development

11.6 Bayer

11.6.1 Bayer Company Details

11.6.2 Bayer Business Overview

11.6.3 Bayer Antifungal Nail Drug Introduction

11.6.4 Bayer Revenue in Antifungal Nail Drug Business (2021–2026)

11.6.5 Bayer Recent Development

11.7 Merck & Co.

11.7.1 Merck & Co. Company Details

11.7.2 Merck & Co. Business Overview

11.7.3 Merck & Co. Antifungal Nail Drug Introduction

11.7.4 Merck & Co. Revenue in Antifungal Nail Drug Business (2021–2026)

11.7.5 Merck & Co. Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Details

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Antifungal Nail Drug Introduction

11.8.4 AstraZeneca Revenue in Antifungal Nail Drug Business (2021–2026)

11.8.5 AstraZeneca Recent Development

11.9 Europharma

11.9.1 Europharma Company Details

11.9.2 Europharma Business Overview

11.9.3 Europharma Antifungal Nail Drug Introduction

11.9.4 Europharma Revenue in Antifungal Nail Drug Business (2021–2026)

11.9.5 Europharma Recent Development

11.10 CR Sanjiu

11.10.1 CR Sanjiu Company Details

11.10.2 CR Sanjiu Business Overview

11.10.3 CR Sanjiu Antifungal Nail Drug Introduction

11.10.4 CR Sanjiu Revenue in Antifungal Nail Drug Business (2021–2026)

11.10.5 CR Sanjiu Recent Development

11.11 Taiji Group

11.11.1 Taiji Group Company Details

11.11.2 Taiji Group Business Overview

11.11.3 Taiji Group Antifungal Nail Drug Introduction

11.11.4 Taiji Group Revenue in Antifungal Nail Drug Business (2021–2026)

11.11.5 Taiji Group Recent Development

11.12 Tonrentang

11.12.1 Tonrentang Company Details

11.12.2 Tonrentang Business Overview

11.12.3 Tonrentang Antifungal Nail Drug Introduction

11.12.4 Tonrentang Revenue in Antifungal Nail Drug Business (2021–2026)

11.12.5 Tonrentang Recent Development

11.13 3M Health Care

11.13.1 3M Health Care Company Details

11.13.2 3M Health Care Business Overview

11.13.3 3M Health Care Antifungal Nail Drug Introduction

11.13.4 3M Health Care Revenue in Antifungal Nail Drug Business (2021–2026)

11.13.5 3M Health Care Recent Development

11.14 Galderma

11.14.1 Galderma Company Details

11.14.2 Galderma Business Overview

11.14.3 Galderma Antifungal Nail Drug Introduction

11.14.4 Galderma Revenue in Antifungal Nail Drug Business (2021–2026)

11.14.5 Galderma Recent Development

11.15 Letai Pharma

11.15.1 Letai Pharma Company Details

11.15.2 Letai Pharma Business Overview

11.15.3 Letai Pharma Antifungal Nail Drug Introduction

11.15.4 Letai Pharma Revenue in Antifungal Nail Drug Business (2021–2026)

11.15.5 Letai Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Antifungal Nail Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Azoles

Table 3. Key Players of Allylamines

Table 4. Key Players of Morpholines

Table 5. Key Players of Polyene Antifungals

Table 6. Global Antifungal Nail Drug Market Size Growth Rate by End Users (US$ Million): 2021 vs 2025 vs 2032

Table 7. Key Players of Dermatology Clinic

Table 8. Key Players of General Hospital

Table 9. Key Players of Home Care

Table 10. Global Antifungal Nail Drug Market Size Growth Rate by Administration Route (US$ Million): 2021 vs 2025 vs 2032

Table 11. Key Players of Topical Drugs

Table 12. Key Players of Oral Drugs

Table 13. Global Antifungal Nail Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 14. Global Antifungal Nail Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global Antifungal Nail Drug Market Size by Region (US$ Million), 2021–2026

Table 16. Global Antifungal Nail Drug Market Share by Region (2021–2026)

Table 17. Global Antifungal Nail Drug Forecasted Market Size by Region (US$ Million), 2027–2032

Table 18. Global Antifungal Nail Drug Market Share by Region (2027–2032)

Table 19. Antifungal Nail Drug Market Trends

Table 20. Antifungal Nail Drug Market Drivers

Table 21. Antifungal Nail Drug Market Challenges

Table 22. Antifungal Nail Drug Market Restraints

Table 23. Global Antifungal Nail Drug Revenue by Players (US$ Million), 2021–2026

Table 24. Global Antifungal Nail Drug Market Share by Players (2021–2026)

Table 25. Global Top Antifungal Nail Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Antifungal Nail Drug Revenue, 2025

Table 26. Ranking of Global Top Antifungal Nail Drug Companies by Revenue (US$ Million) in 2025

Table 27. Global 5 Largest Players Market Share by Antifungal Nail Drug Revenue (CR5 and HHI), 2021–2026

Table 28. Global Key Players of Antifungal Nail Drug, Headquarters and Area Served

Table 29. Global Key Players of Antifungal Nail Drug, Products and Applications

Table 30. Global Key Players of Antifungal Nail Drug, Date of General Availability (GA)

Table 31. Mergers and Acquisitions, Expansion Plans

Table 32. Global Antifungal Nail Drug Market Size by Type (US$ Million), 2021–2026

Table 33. Global Antifungal Nail Drug Revenue Market Share by Type (2021–2026)

Table 34. Global Antifungal Nail Drug Forecasted Market Size by Type (US$ Million), 2027–2032

Table 35. Global Antifungal Nail Drug Revenue Market Share by Type (2027–2032)

Table 36. Global Antifungal Nail Drug Market Size by Application (US$ Million), 2021–2026

Table 37. Global Antifungal Nail Drug Revenue Market Share by Application (2021–2026)

Table 38. Global Antifungal Nail Drug Forecasted Market Size by Application (US$ Million), 2027–2032

Table 39. Global Antifungal Nail Drug Revenue Market Share by Application (2027–2032)

Table 40. North America Antifungal Nail Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. North America Antifungal Nail Drug Market Size by Country (US$ Million), 2021–2026

Table 42. North America Antifungal Nail Drug Market Size by Country (US$ Million), 2027–2032

Table 43. Europe Antifungal Nail Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Europe Antifungal Nail Drug Market Size by Country (US$ Million), 2021–2026

Table 45. Europe Antifungal Nail Drug Market Size by Country (US$ Million), 2027–2032

Table 46. Asia-Pacific Antifungal Nail Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 47. Asia-Pacific Antifungal Nail Drug Market Size by Region (US$ Million), 2021–2026

Table 48. Asia-Pacific Antifungal Nail Drug Market Size by Region (US$ Million), 2027–2032

Table 49. Latin America Antifungal Nail Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 50. Latin America Antifungal Nail Drug Market Size by Country (US$ Million), 2021–2026

Table 51. Latin America Antifungal Nail Drug Market Size by Country (US$ Million), 2027–2032

Table 52. Middle East & Africa Antifungal Nail Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 53. Middle East & Africa Antifungal Nail Drug Market Size by Country (US$ Million), 2021–2026

Table 54. Middle East & Africa Antifungal Nail Drug Market Size by Country (US$ Million), 2027–2032

Table 55. Pfizer Company Details

Table 56. Pfizer Business Overview

Table 57. Pfizer Antifungal Nail Drug Product

Table 58. Pfizer Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 59. Pfizer Recent Development

Table 60. Bausch Health Company Details

Table 61. Bausch Health Business Overview

Table 62. Bausch Health Antifungal Nail Drug Product

Table 63. Bausch Health Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 64. Bausch Health Recent Development

Table 65. Novartis Company Details

Table 66. Novartis Business Overview

Table 67. Novartis Antifungal Nail Drug Product

Table 68. Novartis Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 69. Novartis Recent Development

Table 70. GSK Company Details

Table 71. GSK Business Overview

Table 72. GSK Antifungal Nail Drug Product

Table 73. GSK Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 74. GSK Recent Development

Table 75. Sanofi Company Details

Table 76. Sanofi Business Overview

Table 77. Sanofi Antifungal Nail Drug Product

Table 78. Sanofi Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 79. Sanofi Recent Development

Table 80. Bayer Company Details

Table 81. Bayer Business Overview

Table 82. Bayer Antifungal Nail Drug Product

Table 83. Bayer Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 84. Bayer Recent Development

Table 85. Merck & Co. Company Details

Table 86. Merck & Co. Business Overview

Table 87. Merck & Co. Antifungal Nail Drug Product

Table 88. Merck & Co. Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 89. Merck & Co. Recent Development

Table 90. AstraZeneca Company Details

Table 91. AstraZeneca Business Overview

Table 92. AstraZeneca Antifungal Nail Drug Product

Table 93. AstraZeneca Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 94. AstraZeneca Recent Development

Table 95. Europharma Company Details

Table 96. Europharma Business Overview

Table 97. Europharma Antifungal Nail Drug Product

Table 98. Europharma Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 99. Europharma Recent Development

Table 100. CR Sanjiu Company Details

Table 101. CR Sanjiu Business Overview

Table 102. CR Sanjiu Antifungal Nail Drug Product

Table 103. CR Sanjiu Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 104. CR Sanjiu Recent Development

Table 105. Taiji Group Company Details

Table 106. Taiji Group Business Overview

Table 107. Taiji Group Antifungal Nail Drug Product

Table 108. Taiji Group Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 109. Taiji Group Recent Development

Table 110. Tonrentang Company Details

Table 111. Tonrentang Business Overview

Table 112. Tonrentang Antifungal Nail Drug Product

Table 113. Tonrentang Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 114. Tonrentang Recent Development

Table 115. 3M Health Care Company Details

Table 116. 3M Health Care Business Overview

Table 117. 3M Health Care Antifungal Nail Drug Product

Table 118. 3M Health Care Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 119. 3M Health Care Recent Development

Table 120. Galderma Company Details

Table 121. Galderma Business Overview

Table 122. Galderma Antifungal Nail Drug Product

Table 123. Galderma Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 124. Galderma Recent Development

Table 125. Letai Pharma Company Details

Table 126. Letai Pharma Business Overview

Table 127. Letai Pharma Antifungal Nail Drug Product

Table 128. Letai Pharma Revenue in Antifungal Nail Drug Business (US$ Million), 2021–2026

Table 129. Letai Pharma Recent Development

Table 130. Research Programs/Design for This Report

Table 131. Key Data Information from Secondary Sources

Table 132. Key Data Information from Primary Sources

Table 133. Authors List of This Report

List of Figures

Figure 1. Antifungal Nail Drug Picture

Figure 2. Global Antifungal Nail Drug Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Antifungal Nail Drug Market Share by Type: 2025 vs 2032

Figure 4. Azoles Features

Figure 5. Allylamines Features

Figure 6. Morpholines Features

Figure 7. Polyene Antifungals Features

Figure 8. Global Antifungal Nail Drug Market Size Comparison by End Users (US$ Million), 2021–2032

Figure 9. Dermatology Clinic Features

Figure 10. General Hospital Features

Figure 11. Home Care Features

Figure 12. Global Antifungal Nail Drug Market Size Comparison by Administration Route (US$ Million), 2021–2032

Figure 13. Topical Drugs Features

Figure 14. Oral Drugs Features

Figure 15. Global Antifungal Nail Drug Market Size by Application (US$ Million), 2021–2032

Figure 16. Global Antifungal Nail Drug Market Share by Application: 2025 vs 2032

Figure 17. Hospital Sales Case Studies

Figure 18. Retail Pharmacy Case Studies

Figure 19. Other Case Studies

Figure 20. Antifungal Nail Drug Report Years Considered

Figure 21. Global Antifungal Nail Drug Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Antifungal Nail Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Antifungal Nail Drug Market Share by Region: 2025 vs 2032

Figure 24. Global Antifungal Nail Drug Market Share by Players in 2025

Figure 25. Global Antifungal Nail Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Antifungal Nail Drug Revenue in 2025

Figure 27. North America Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Antifungal Nail Drug Market Share by Country (2021–2032)

Figure 29. United States Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Antifungal Nail Drug Market Share by Country (2021–2032)

Figure 33. Germany Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Antifungal Nail Drug Market Share by Region (2021–2032)

Figure 41. China Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Antifungal Nail Drug Market Share by Country (2021–2032)

Figure 49. Mexico Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Antifungal Nail Drug Market Share by Country (2021–2032)

Figure 53. Israel Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Antifungal Nail Drug Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Pfizer Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 57. Bausch Health Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 58. Novartis Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 59. GSK Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 60. Sanofi Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 61. Bayer Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 62. Merck & Co. Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 63. AstraZeneca Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 64. Europharma Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 65. CR Sanjiu Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 66. Taiji Group Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 67. Tonrentang Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 68. 3M Health Care Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 69. Galderma Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 70. Letai Pharma Revenue Growth Rate in Antifungal Nail Drug Business (2021–2026)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions